Neurosurgeons share their insights on how innovation is closing the gap between clinical needs and the availability of pediatric devices.
Three-stage DBS results in better outcomes for secondary dystonia
A CHOC neuroscientist has developed a breakthrough method of DBS to treat secondary dystonia in pediatric patients.
CHOC awarded $2.3-million grant to study how toxic stress and unpredictability in the early environment affects neurodevelopment
CHOC, in partnership with UC Irvine & Chapman University, received a grant to screen patients for adverse childhood experiences.
Batten disease patients highlight CHOC’s growing reputation as a destination for kids with rare conditions
Children from throughout the U.S. travel to receive CLN2 treatment at CHOC, the largest Brineura infusion center in the nation.
Dr. Mary Zupanc awarded prestigious Arnold P. Gold Humanism in Medicine Award
Dr. Mary Zupanc has achieved many awards, but considers the Arnold P. Gold Foundation Humanism in Medicine Award her highest honor of all.
Personalized medicine, surgical innovations advance pediatric brain tumor care
The Neuro-Oncology Treatment Program at CHOC is helping to shape the future of personalized medicine and surgical innovations.
